Dean N. DiMaria
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Dean N. DiMaria
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
NXXI, Inc.
 NXXI, Inc. Pharmaceuticals: MajorHealth Technology NXXI, Inc. operates as a nutritional bioscience company. It primarily develops and markets raw materials, formulations, compounds, blends and bulk and other materials to third-party non-end users to be further fabricated, blended or packaged for ultimate sales to end-users as nutritional supplements. The company was founded on June 29, 1983 and is headquartered in Purchase, NY.
8
| Private Company | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dean N. DiMaria
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PROCTER & GAMBLE COMPANY | Household/Personal Care | Corporate Officer/Principal | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Medtech Holdings, Inc.
 Medtech Holdings, Inc. Wholesale DistributorsDistribution Services Part of Prestige Consumer Healthcare, Inc., Medtech Holdings, Inc. distributes branded health and beauty care products. The company is based in Irvington, NY. Daniel C. Croteau has been the CEO of the company since 2011. | Wholesale Distributors | President Sales & Marketing | |
| PRESTIGE CONSUMER HEALTHCARE INC. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing Sales & Marketing | |
| SCRIPSAMERICA, INC. | Medical Distributors | Director/Board Member | |
| Brown University | College/University | Doctorate Degree Undergraduate Degree | |
LipoGenics, Inc.
 LipoGenics, Inc. Food: Meat/Fish/DairyConsumer Non-Durables Part of NutraGenics, Inc. (Arizona), LipoGenics, Inc. manufactures dietary supplements. The company is based in Phoenix, AZ. The company was founded by Leaf Huang. LipoGenics was acquired by NutraGenics, Inc. (Arizona) on October 31, 1996. | Food: Meat/Fish/Dairy | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| American University | College/University | Undergraduate Degree | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Fish & Neave LLP
 Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Manhattan College | College/University | Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin | |
| University of Manitoba | College/University | Undergraduate Degree | |
| Villanova University | College/University | Undergraduate Degree | |
| Baruch College | College/University | Graduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree | |
Microbiotix, Inc.
 Microbiotix, Inc. Pharmaceuticals: MajorHealth Technology Microbiotix, Inc. is a clinical stage biopharmaceutical company located in Worcester, MA. The private company's lead therapeutic compound, mbx-400, is a potent and novel nucleoside analog dual DNA polymerase/kinase inhibitor for the treatment of human cytomegalovirus (CMV). Microbiotix has consistently been the top recipient of NIH awards amongst biotech/pharma companies, which is a testament to their innovation. The company was founded by Wendy E. Rieder and is focused on the discovery and development of proprietary small molecule drugs that target serious infectious diseases, including multi-drug resistant pathogens. | Pharmaceuticals: Major | Founder | |
| Hahnemann University | College/University | Doctorate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Corporate Officer/Principal | |
Henry Ford Hospital
 Henry Ford Hospital Hospital/Nursing ManagementHealth Services Henry Ford Hospital operates hospitals. The private company is based in Detroit, MI and has subsidiaries in United States. Richard O. Davis has been the CEO of the company since 2018. | Hospital/Nursing Management | Corporate Officer/Principal | |
Ischemix, Inc.
 Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Blacksmith Brands, Inc.
 Blacksmith Brands, Inc. Pharmaceuticals: OtherHealth Technology Blacksmith Brands, Inc. operates as a platform company to invest in over-the-consumer products brands. It also markets over-the-counter drug and personal care products. The firm's brands include EFFERDENT, EFFERGRIP and PEDIACARE. The company was founded by Peter C. Mann and Dana L. Schmaltz in 2009 and is headquartered in Tarrytown, NY. | Pharmaceuticals: Other | Founder Sales & Marketing Sales & Marketing | |
Yellow Wood Partners LLC
 Yellow Wood Partners LLC Investment ManagersFinance Yellow Wood Partners LLC (Yellow Wood Partners) is a private equity firm founded in 2009 by Dana Schmaltz and Peter Mann. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Corporate Officer/Principal | |
| Fordham University School of Law | College/University | Graduate Degree | |
| COCRYSTAL PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The RNA Society
 The RNA Society Miscellaneous Commercial ServicesCommercial Services The RNA Society is a non-profit international scientific society. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Us India Chamber of Commerce | Corporate Officer/Principal | ||
| BIOXCEL THERAPEUTICS, INC. | Biotechnology | Chairman | |
American Society for the Advancement of Pharmacotherapy
 American Society for the Advancement of Pharmacotherapy Hospital/Nursing ManagementHealth Services The American Society for the Advancement of Pharmacotherapy provides psychological treatments combined with psychopharmacological medications. The non-profit company is based in Washington. | Hospital/Nursing Management | Corporate Officer/Principal | |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Founder | |
| Mueller Health Foundation, Inc. | President | ||
| PARADIGM BIOPHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 47 |
| Kanada | 3 |
| Schweden | 2 |
| Australien | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 4 |
| Consumer Non-Durables | 3 |
| Distribution Services | 3 |
Operativ
| Corporate Officer/Principal | 72 |
| Director/Board Member | 52 |
| Chief Tech/Sci/R&D Officer | 28 |
| President | 20 |
| Undergraduate Degree | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Stephen K. Carter | 20 |
| Peter C. Mann | 20 |
| Mikael Dolsten | 19 |
| J. Carroll | 17 |
| Peter Mueller | 15 |
| Albert Agro | 13 |
| S. Michael Imperiale | 10 |
| Burkhard Blank | 10 |
| Michael A. Fink | 10 |
| Michael A. Zeher | 9 |
| Scott Terrillion | 8 |
| Wendy E. Rieder | 8 |
| James Gregory Ford | 8 |
| Gerard F. Butler | 7 |
| Douglas L. Mayers | 7 |
- Börse
- Insiders
- Dean N. DiMaria
- Unternehmensverbindungen
